Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för GI254023X. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2017-08-11

Ectodomain shedding of Limbic System-Associated Membrane Protein (LSAMP) by ADAM Metallopeptidases promotes neurite outgrowth in DRG neurons.

Sanz RL, Ferraro GB, Girouard MP, Fournier AE.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-017-08315-0

Bibliografisk träff 2016-08-22

Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes.

O'Sullivan SA, Gasparini F, Mir AK, Dev KK.

J Neuroinflammation · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12974-016-0659-7

Bibliografisk träff 2016-03-30

ADAM10 Cell Surface Expression but Not Activity Is Critical for Staphylococcus aureus α-Hemolysin-Mediated Activation of the NLRP3 Inflammasome in Human Monocytes.

Ezekwe EA, Weng C, Duncan JA.

Toxins (Basel) · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.3390/toxins8040095

Bibliografisk träff 2015-12-01

[Effect of ADAM10 Inhibitor GI254023X on Proliferation and Apoptosis of Multiple Myeloma H929 Cells and Its Possible Mechanisms].

Chen LL, Fan GQ, Zhang ZY, Zhang BY, Yan ZL, Li HJ, Luo JP, Chen C, Yao Y, Xu KL, Li ZY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi · journal article · DOI 10.7534/j.issn.1009-2137.2015.06.019

Bibliografisk träff 2015-08-01

[Effect of ADAM10 Inhibitor GI254023X on Proliferation and Apoptosis of Acute T-Lymphoblastic Leukemia Jurkat Cells In Vitro and Its Possible Mechanisms].

Ma S, Xu J, Wang X, Wu QY, Cao J, Li ZY, Zeng LY, Chen C, Xu KL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi · journal article · DOI 10.7534/j.issn.1009-2137.2015.04.008

Bibliografisk träff 2014-02-11

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.

Gooden MJ, Wiersma VR, Boerma A, Leffers N, Boezen HM, ten Hoor KA, Hollema H, Walenkamp AM, Daemen T, Nijman HW, Bremer E.

Br J Cancer · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/bjc.2014.55

Bibliografisk träff 2010-02-27

Improved synthesis of ADAM10 inhibitor GI254023X.

Hoettecke N, Ludwig A, Foro S, Schmidt B.

Neurodegener Dis · research support, non-u.s. gov't; journal article · DOI 10.1159/000267865

Bibliografisk träff 2003-04-24

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A.

Blood · research support, non-u.s. gov't; journal article · DOI 10.1182/blood-2002-12-3775